News

California residents can now buy the overdose reversal nasal spray naloxone directly from the state through the CalRx program ...
Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.
The tariff war has prompted new calls to reshore manufacturing. Several large pharmas have already made the leap.
Nonprofit drugmaker Civica Rx is investing $27.8 million to establish a new 55,000-square-foot laboratory in Chesterfield County’s Meadowville Technology Park, Gov. Glenn Youngkin announced Thursday.
Dafny, Leemore S. "Civica Rx: A Not-for-Profit Founded to Address Market Failures in the Generic Drug Industry." Harvard Business School Case 324-057, February 2024.
Melanie Evans covered the hospital industry for The Wall Street Journal in New York. She reported on the business of running ...
CivicaScript — which manufactures and distributes low-cost, outpatient generic medications — is a sister company to Civica Inc. (Civica Rx). Health systems formed Civica in 2018 to address ...
Vizient, a healthcare performance improvement company, will use its analytics and data capabilities to help Civica Rx anticipate gaps in drug availability and affordability. Hospitals across the ...